INS and hyperinsulinism: Using multiple models of mammary carcinoma, these investigators demonstrated that hyperinsulinemia promotes mammary tumor growth and pulmonary metastasis and that treatment with an insulin sensitizer or a small-molecule IR/IGF-IR inhibitor can attenuate these effects (44–47).